News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aileron Therapeutics Reports Second Quarter 2017 Financial Results



8/11/2017 11:02:12 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
CAMBRIDGE, Mass., Aug. 10, 2017 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN), the clinical-stage leader in the field of stapled peptide therapeutics for cancers and other diseases, today reported financial results for the second quarter ended June 30, 2017, and provided an update on recent developments.

“The first half of the year was highly productive for our Company, marked by significant progress across multiple clinical studies with our lead product candidate, and operationally, with the completion of a successful IPO,” said Joseph A. Yanchik III, President and CEO.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES